إنتاج الأموكسيسيلين شبه الصنعي

المضاد الحيوي الأكثر وصفاً في العالم

Pharmaceutical & Drug Manufacturing Global Industrial Scale $2.5 billion

نظرة عامة

Amoxicillin is a broad-spectrum semi-synthetic penicillin and the most prescribed antibiotic globally. It is produced by enzymatic coupling of 6-aminopenicillanic acid (6-APA) with D-p-hydroxyphenylglycine (D-HPG) using penicillin G acylase. This enzymatic route has largely replaced chemical acylation methods, providing higher selectivity, milder conditions, and dramatically reduced solvent waste. The process exemplifies the successful integration of biocatalysis in pharmaceutical manufacturing.

العملية الكيميائية

6-APA is obtained by enzymatic deacylation of penicillin G using immobilized penicillin G acylase. The 6-APA is then coupled with activated D-HPG methyl ester using the same or similar acylase enzyme under controlled pH and temperature to produce amoxicillin trihydrate.

6-APA + D-HPG-OMe →[Penicillin G acylase, pH 6.5, 25 degrees C] Amoxicillin + CH₃OH

المواد الخام

  • 6-APA (6-aminopenicillanic acid) — Enzymatic cleavage of penicillin G (Beta-lactam core)
  • D-p-Hydroxyphenylglycine (D-HPG) — Enzymatic resolution or fermentation (Side-chain amino acid)
  • Penicillin G acylase (enzyme) — Recombinant E. coli (Biocatalyst)

المنتجات النهائية

  • Amoxicillin trihydrate (C₁₆H₁₉N₃O₅S·3H₂O) — Broad-spectrum antibiotic (Compendial grade)
<path stroke-linecap="round" stroke-linejoin="round" d="M12 9v3.75m-9.303 3.376c-.866 1.5.217 3.374 1.948 3.374h14.71c1.73 0 2.813-1.874 1.948-3.374L13.949 3.378c-.866-1.5-3.032-1.5-3.898 0L2.697 16.126zM12 15.75h.007v.008H12v-.008z" />

Environmental Impact

The enzymatic process is significantly greener than chemical acylation, eliminating the need for silylation reagents, organic solvents, and cryogenic conditions. Immobilized enzymes can be reused hundreds of times. Wastewater treatment is simplified due to reduced chemical usage.

اعتبارات السلامة

الابتكارات الحديثة

New engineered acylases with improved thermostability and selectivity are enabling fully aqueous, room-temperature synthesis.
Integration of continuous enzymatic reactors with in-line crystallization is reducing production costs in developing countries.

حجم الإنتاج

21000

طن/سنة

$2.5 billion

القيمة السوقية

المزيد في %(name)s Pharmaceutical & Drug Manufacturing

إنتاج الإنسولين البشري المؤتلف

Global Industrial Scale

إنتاج البنسلين G بالتخمير

Global Industrial Scale

تخليق أوميبرازول لمثبطات مضخة البروتون

Global Industrial Scale

تخليق الأسبرين عبر أستلة حمض الساليسيليك

Global Industrial Scale

تخليق الإيبوبروفين — عملية BHC الخضراء

Global Industrial Scale

تخليق الباراسيتامول (الأسيتامينوفين)

Global Industrial Scale

تخليق هيدروكلوريد الميتفورمين

Global Industrial Scale

Frequently Asked Questions

What industry uses إنتاج الأموكسيسيلين شبه الصنعي?
إنتاج الأموكسيسيلين شبه الصنعي is used in the pharmaceutical & drug manufacturing sector at global industrial scale scale.
What process is involved in إنتاج الأموكسيسيلين شبه الصنعي?
6-APA is obtained by enzymatic deacylation of penicillin G using immobilized penicillin G acylase. The 6-APA is then coupled with activated D-HPG methyl ester using the same or similar acylase enzyme under controlled pH and temperature to produce amoxicillin trihydrate.
What is the economic significance of إنتاج الأموكسيسيلين شبه الصنعي?
إنتاج الأموكسيسيلين شبه الصنعي has a market value of $2.5 billion and annual production of 21,000 tons.
What is the environmental impact of إنتاج الأموكسيسيلين شبه الصنعي?
The enzymatic process is significantly greener than chemical acylation, eliminating the need for silylation reagents, organic solvents, and cryogenic conditions. Immobilized enzymes can be reused hundreds of times. Wastewater treatment is simplified due to reduced chemical usage.
What raw materials are used in إنتاج الأموكسيسيلين شبه الصنعي?
The main raw materials include: 6-APA (6-aminopenicillanic acid), D-p-Hydroxyphenylglycine (D-HPG), Penicillin G acylase (enzyme).